My mother, who was once the primary caretaker of her husband and three kids, who worked as a substitute teacher and part time editor of the Harvard Business Review, who threw amazing parties and volunteered at the temple and ran a gourmet catering business in her spare time, has Alzheimer's Disease, just as her mother and brother had it before her.
Science isn't going to be advanced by scientists alone: Communication and information must also be open and easily accessible to the vast cancer community they serve. Patients and their families need a single portal -- not a Byzantine maze -- to learn about clinical trials, data, research, drugs and other therapies.
Recently, NEJM Editor-in-Chief Jeffrey Drazen and his senior editors have shown a disturbing disregard for the journal's traditionally high standards. This became most apparent when, in 2013, they published a series of pieces that provided a misleading and unbalanced assessment of an unethical clinical trial involving more than 1,300 premature babies.